Study on the Complex Melanoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 26 April 2024 | Viewed by 43691
Special Issue Editor
Special Issue Information
Dear Colleagues,
Melanoma, the deadliest form of skin cancer, remains one of the most difficult cancers to treat despite recent advances in targeted and immune-therapies. Several driver oncogenes and tumor suppressor genes have been linked with the onset and progression of melanoma in experimental model systems, but alterations in expression and signaling cascades have demonstrated the complexity of this disease, and much remains to be uncovered to improve therapeutic outcomes.
This Special Issue on Cancers invites a range of papers, from original research articles to comprehensive reviews on melanoma.
Prof. Suzie Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanocyte
- nevi
- melanoma
- metastasis
- mutations
- targeted therapies
- immunotherapies
- onset of resistance
- tumor microenvironment